Login to Your Account



MediciNova $44M Financing To Advance Products To Phase II

By Karen Pihl-Carey


Tuesday, September 7, 2004
As it prepares to move three products into Phase II studies, MediciNova Inc. raised $44 million in a Series C round. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription